NOVELOS THERAPEUTICS, INC.NEWTON, MASSACHUSETTS

Company Information

Products & Services

antibody, antibodies, ap1, bam, bam ltd., bam-002, bam-cln-01, biotechnology, blood, cancer, carboplatin, cell, cell cycle, cell function, cellular metabolism, cellular redox state, chemo, chemotherapy, chemotherapy courses, chemotherapy regimens, clinical, clinical development, clinical program, clinical studies, clinical trials, cytokine levels, delivery, drug, fda, hematocrit, hematology, hematological, hematopoeitic, hematopoeitic recovery, hemoglobin, hepatitis, immune system, immunology, immunologic, immunological, immunoprotective, immunostimulative, infectious diseases, inhibitory modulation, intracellular systems, intravenous delivery, investigational new drug, malignancy, malignant, metabolic modulators, metastasis, metastatic, modulation, molecular mechanisms, nervous system, new drug, nf-k, non-small cell lung cancer, nsclc, oncology, oncologic, oncological, one-year survival rate, paclitaxel, pathology, pathologic, pathological, pharmaceutical, pharmacology, pharmacologic, pharmacological, platelet differential, platform technology, progression, radiation, radiation therapy, ras proteins, side effects, signaling pathways, subcutaneous delivery, surgery, survival rate, t-cell, therapeutics, therapy, toxic, toxicity, toxicology, toxicological, transcription factors, transfusion support, tumor, tumor response, vaccines, viral infection, virally infected, virus, white blood cells, novelos, novelis, novelos therapeutics

novelos therapeutics, inc. was founded in 1996 to commercialize a promising, novel platform technology developed by bam ltd., a russian biotechnology company. this platform has led to the identification of a novel class of metabolic modulators of cell cycle and function.